Hypertension Clinical Trial
Official title:
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome, Abdominal Obesity and Arterial Hypertension, and Quality of Life in the Climacteric Period
Verified date | May 2022 |
Source | Universidad de Concepcion |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The estrogenic deficit characteristic of the climacteric stage is accompanied by a high incidence of health problems, such as the presence of Metabolic Syndrome risk factors that contribute to the increase of cardiovascular diseases. Objective: To determine the effect of a nursing intervention based on self-care aimed at improving the control of two metabolic syndrome risk factors (abdominal obesity and arterial hypertension) and health-related quality of life in climacteric women. Material and methods: Quasi-experimental study, non-equivalent control group design with women between 40 and 59 years old who present two risk factors of the Metabolic Syndrome (abdominal obesity and arterial hypertension) from two type C Health Centers of District 17D03 of Quito, Ecuador. Among one of the conceptual hypotheses, the researchers have Conceptual hypothesis 1: Climacteric women of the experimental group after the intervention of Nursing based on self-care improve two risk factors of MS with respect to those of the comparison group. A sample of 40 women was selected for experimental group and 40 for comparison group. Instruments and measurements: Abdominal Circumference, Blood Pressure, Menopause Rating Scale, International Physical Activity Questionnaire (IPAQ). Women in both groups received the usual care and those in the experimental group received a Nursing Intervention with technological support that included individual face-to-face nursing counseling, group education and physical activity sessions through a virtual platform for 12 weeks. Ethical requirements were considered. Expected results: It is expected that after the Nursing Intervention based on self-care the women of the experimental group will decrease the parameters of abdominal circumference, blood pressure and improve health-related quality of life.
Status | Completed |
Enrollment | 80 |
Est. completion date | December 22, 2021 |
Est. primary completion date | September 11, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 40 Years to 59 Years |
Eligibility | Inclusion Criteria: - Be between 40 and 59 years of age. - Abdominal circumference equal to or greater than 80 cm. - Blood pressure equal to or greater than 130/85mmHg or on antihypertensive treatment - Being able to ambulate without assistance. - Population residing in the sector in which you are registered. - Access to mobile or fixed internet service. Exclusion Criteria: - Women on hormone replacement therapy. - Women with hysterectomy and/or oophorectomy - Pregnant women. - Women with cardiovascular disease such as dyslipidemia, type II diabetes; cancer; hypothyroidism; respiratory disease; neuromuscular or terminal illness. - People who cannot read or write. |
Country | Name | City | State |
---|---|---|---|
Ecuador | Centro de Salud de San Antonio de Pichincha | Quito | Pichincha |
Lead Sponsor | Collaborator |
---|---|
Universidad de Concepcion | Universidad Central del Ecuador |
Ecuador,
Šabanovic Š, Ljiljana MT, Babic F, Vadovský M, Paralic J, Vcev A, Holzinger A. Metabolic syndrome in hypertensive women in the age of menopause: a case study on data from general practice electronic health records. BMC Med Inform Decis Mak. 2018 Apr 2;18( — View Citation
Aleyasin SA, Navidi T, Davoudi S. Association between rs10757274 and rs2383206 SNPs as Genetic Risk Factors in Iranian Patients with Coronary Artery Disease. J Tehran Heart Cent. 2017 Jul;12(3):114-118. — View Citation
Beckie TM, Beckstead JW, Groer MW. The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. J Cardiovasc Nurs. 2010 Jan-Feb;25(1):52-60. doi: 10.1097/JCN.0b013e3181b7e500. — View Citation
Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007 Oct;3(10):696-704. Review. — View Citation
Blumenthal JA, Babyak MA, Sherwood A, Craighead L, Lin PH, Johnson J, Watkins LL, Wang JT, Kuhn C, Feinglos M, Hinderliter A. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on ins — View Citation
Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas. 2007 Jul 20;57(3):271-8. Epub 2007 Feb 27. — View Citation
Chedraui P, Blümel JE, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, T — View Citation
Chedraui P, Pérez-López FR, Mendoza M, Morales B, Martinez MA, Salinas AM, Hidalgo L. Severe menopausal symptoms in middle-aged women are associated to female and male factors. Arch Gynecol Obstet. 2010 May;281(5):879-85. doi: 10.1007/s00404-009-1204-z. E — View Citation
Chiang LC, Heitkemper MM, Chiang SL, Tzeng WC, Lee MS, Hung YJ, Lin CH. Motivational Counseling to Reduce Sedentary Behaviors and Depressive Symptoms and Improve Health-Related Quality of Life Among Women With Metabolic Syndrome. J Cardiovasc Nurs. 2019 J — View Citation
Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N, Simoncini T. Menopause. Nat Rev Dis Primers. 2015 Apr 23;1:15004. doi: 10.1038/nrdp.2015.4. Review. — View Citation
Giannouli P, Zervas I, Armeni E, Koundi K, Spyropoulou A, Alexandrou A, Kazani A, Areti A, Creatsa M, Lambrinoudaki I. Determinants of quality of life in Greek middle-age women: a population survey. Maturitas. 2012 Feb;71(2):154-61. doi: 10.1016/j.maturit — View Citation
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, M — View Citation
Gonçalves JT, Silveira MF, Campos MC, Costa LH. Overweight and obesity and factors associated with menopause. Cien Saude Colet. 2016 Apr;21(4):1145-56. doi: 10.1590/1413-81232015214.16552015. English, Portuguese. — View Citation
Hayman LL, Berra K, Fletcher BJ, Houston Miller N. The Role of Nurses in Promoting Cardiovascular Health Worldwide: The Global Cardiovascular Nursing Leadership Forum. J Am Coll Cardiol. 2015 Aug 18;66(7):864-866. doi: 10.1016/j.jacc.2015.06.1319. — View Citation
Hwang YS, Park EJ, Choi JG, Kim HE, Park SG, Yoo SM. Relationship between Age at Menarche and Metabolic Syndrome in Premenopausal Women: Korea National Health and Nutrition Examination Survey 2013-2014. Korean J Fam Med. 2018 Sep;39(5):300-306. doi: 10.40 — View Citation
Kim HR, Kim HS. Optimal Cutoffs of Cardiometabolic Risk for Postmenopausal Korean Women. Asian Nurs Res (Korean Soc Nurs Sci). 2017 Jun;11(2):107-112. doi: 10.1016/j.anr.2017.05.003. Epub 2017 Jun 1. — View Citation
Kozakowski J, Gietka-Czernel M, Leszczynska D, Majos A. Obesity in menopause - our negligence or an unfortunate inevitability? Prz Menopauzalny. 2017 Jun;16(2):61-65. doi: 10.5114/pm.2017.68594. Epub 2017 Jun 30. Review. — View Citation
Lee WJ, Yoon JW, Lee JH, Kwag BG, Chang SH, Choi YJ. Effects of Age at First Childbirth and Other Factors on Central Obesity in Postmenopausal Women: The 2013-2015 Korean National Health and Nutrition Examination Survey. Korean J Fam Med. 2018 May;39(3):1 — View Citation
Lim H, Son JY, Choue R. Effects of medical nutrition therapy on body fat and metabolic syndrome components in premenopausal overweight women. Ann Nutr Metab. 2012;61(1):47-56. doi: 10.1159/000339262. Epub 2012 Jul 20. — View Citation
Lin CH, Chiang SL, Heitkemper MM, Hung YJ, Lee MS, Tzeng WC, Chiang LC. Effects of telephone-based motivational interviewing in lifestyle modification program on reducing metabolic risks in middle-aged and older women with metabolic syndrome: A randomized — View Citation
Mattei J, Tamez M, Ríos-Bedoya CF, Xiao RS, Tucker KL, Rodríguez-Orengo JF. Health conditions and lifestyle risk factors of adults living in Puerto Rico: a cross-sectional study. BMC Public Health. 2018 Apr 12;18(1):491. doi: 10.1186/s12889-018-5359-z. — View Citation
Miguel-Soca PE, Rivas-Estévez M, Sarmiento-Teruel Y, Mariño-Soler AL, Marrero-Hidalgo M, Mosqueda-Batista L, Peña-Pérez I, Rivas-Vázquez D, Llorente-Columbié Y. Prevalence of Metabolic Syndrome Risk Factors in Adults in Holguín, Cuba (2004-2013). MEDICC R — View Citation
Montez JK, Bromberger JT, Harlow SD, Kravitz HM, Matthews KA. Life-Course Socioeconomic Status and Metabolic Syndrome Among Midlife Women. J Gerontol B Psychol Sci Soc Sci. 2016 Nov;71(6):1097-1107. Epub 2016 Feb 28. — View Citation
Mozos I, Malainer C, Horbanczuk J, Gug C, Stoian D, Luca CT, Atanasov AG. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Front Immunol. 2017 Aug 31;8:1058. doi: 10.3389/fimmu.2017.01058. eCollection 2017. Review. — View Citation
Núñez-Pizarro JL, González-Luna A, Mezones-Holguín E, Blümel JE, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sánchez H, Tserotas K, V — View Citation
Oh EG, Bang SY, Kim SH, Hyun SS, Chu SH, Jeon JY, Im JA, Lee JE, Lee MK. Therapeutic lifestyle modification program reduces plasma levels of the chemokines CRP and MCP-1 in subjects with metabolic syndrome. Biol Res Nurs. 2013 Jan;15(1):48-55. doi: 10.117 — View Citation
Oh EG, Hyun SS, Kim SH, Bang SY, Chu SH, Jeon JY, Kang MS. A randomized controlled trial of therapeutic lifestyle modification in rural women with metabolic syndrome: a pilot study. Metabolism. 2008 Feb;57(2):255-61. doi: 10.1016/j.metabol.2007.09.009. — View Citation
Oh GC, Kang KS, Park CS, Sung HK, Ha KH, Kim HC, Park S, Ihm SH, Lee HY. Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women. Clin Hypertens. 2018 Oct 15;24:14. doi: 10.1186/s40885-018-0099-z. eCollection 2018. — View Citation
Raczkiewicz D, Owoc A, Wierzbinska-Stepniak A, Bojar I. Metabolic syndrome in peri - and postmenopausal women performing intellectual work. Ann Agric Environ Med. 2018 Dec 20;25(4):610-615. doi: 10.26444/aaem/74451. Epub 2017 Jul 13. — View Citation
Sayan S, Pekin T, Yildizhan B. Relationship between vasomotor symptoms and metabolic syndrome in postmenopausal women. J Int Med Res. 2018 Oct;46(10):4157-4166. doi: 10.1177/0300060518790709. Epub 2018 Aug 9. — View Citation
Sciomer S, Moscucci F, Dessalvi CC, Deidda M, Mercuro G. Gender differences in cardiology: is it time for new guidelines? J Cardiovasc Med (Hagerstown). 2018 Dec;19(12):685-688. doi: 10.2459/JCM.0000000000000719. Review. — View Citation
Shin H, Shin HS. Measurement of quality of life in menopausal women: a systematic review. West J Nurs Res. 2012 Jun;34(4):475-503. doi: 10.1177/0193945911402848. Epub 2011 Mar 25. Review. — View Citation
Taylor JY, Wu CY. Effects of genetic counseling for hypertension on changes in lifestyle behaviors among African-American women. J Natl Black Nurses Assoc. 2009 Jul;20(1):1-10. — View Citation
Tsai SS, Lin YS, Hwang JS, Chu PH. Vital roles of age and metabolic syndrome-associated risk factors in sex-specific arterial stiffness across nearly lifelong ages: Possible implication of menopause and andropause. Atherosclerosis. 2017 Mar;258:26-33. doi — View Citation
Vílchez Barboza V, Klijn TP, Salazar Molina A, Sáez Carrillo KL. Effectiveness of personalized face-to-face and telephone nursing counseling interventions for cardiovascular risk factors: a controlled clinical trial. Rev Lat Am Enfermagem. 2016 Aug 8;24:e — View Citation
Wang CH, Chung MH, Chan P, Tsai JC, Chen FC. Effects of endurance exercise training on risk components for metabolic syndrome, interleukin-6, and the exercise capacity of postmenopausal women. Geriatr Nurs. 2014 May-Jun;35(3):212-8. doi: 10.1016/j.gerinur — View Citation
Williams LT, Hollis JL, Collins CE, Morgan PJ. Can a relatively low-intensity intervention by health professionals prevent weight gain in mid-age women? 12-Month outcomes of the 40-Something randomised controlled trial. Nutr Diabetes. 2014 May 5;4:e116. d — View Citation
Williams LT, Hollis JL, Collins CE, Morgan PJ. The 40-Something randomized controlled trial to prevent weight gain in mid-age women. BMC Public Health. 2013 Oct 25;13:1007. doi: 10.1186/1471-2458-13-1007. — View Citation
Yeh ML, Liao RW, Hsu CC, Chung YC, Lin JG. Exercises improve body composition, cardiovascular risk factors and bone mineral density for menopausal women: A systematic review and meta-analysis of randomized controlled trials. Appl Nurs Res. 2018 Apr;40:90- — View Citation
Yusuf S, Wood D, Ralston J, Reddy KS. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet. 2015 Jul 25;386(9991):399-402. doi: 10.1016/S0140-6736(15)60265-3. Epub 2015 Apr 16. — View Citation
Zajac-Gawlak I, Klapcinska B, Kroemeke A, Pospiech D, Pelclová J, Pridalová M. Associations of visceral fat area and physical activity levels with the risk of metabolic syndrome in postmenopausal women. Biogerontology. 2017 Jun;18(3):357-366. doi: 10.1007 — View Citation
* Note: There are 41 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in abdominal obesity | Anthropometric measurements (abdominal circumference) | Until the end of the study (3 months duration) | |
Primary | Reduce systolic and diastolic blood pressure | Vital sign (systolic and diastolic blood pressure) | Until the end of the study (3 months duration) | |
Primary | Improve health-related quality of life | Instrument Menopause Rating Scale: (Minimum total value "0 points" and maximum "44 points", if the score is higher the result is negative) | Until the end of the study (3 months duration) | |
Secondary | Increase the level of physical activity | International Physical Activity Questionnaire:(Inactive: less than 10 minutes in a row in the last 7 days, Low Activity: between 10 and 149 minutes in the last 7 days and Medium or High Activity: 150 or more minutes in the last 7 days) | Until the end of the study (3 months duration) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A | |
Completed |
NCT04303468 -
Intervention With a GABA Supplement in Prediabetics
|
N/A |